Beijing Med-Pharm Corporation maintained the regular drumbeat pace of its dealmaking by announcing a five-year agreement to distribute another drug in China. The newest addition to BJCP’s portfolio is Ferriprox®, a treatment for iron overload in the bloodstream. It is produced by Apotex, the largest Canadian-owned pharmaceutical company. The drug has already received approval from the FDA in China. More details...

Stock Symbols: (NSDQ: BJGP)